Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant

H Schmidt, J Raasch, D Merkler, F Klinker… - Experimental …, 2009 - Elsevier
H Schmidt, J Raasch, D Merkler, F Klinker, S Krauss, W Brück, M Prinz
Experimental neurology, 2009Elsevier
The type I interferons, interferon-beta and alpha (IFN-β, IFN-α), are widely used for the
treatment of autoimmune demyelination in the central nervous system (CNS). Their effects
on de-and remyelination through the broadly expressed type I IFN receptor (IFNAR),
however, are highly speculative. In order to elucidate the role of endogenous type I
interferons for myelin damage and recovery we induced toxic demyelination in the absence
of IFNAR1. We demonstrate that IFNAR signalling was induced during acute demyelination …
The type I interferons, interferon-beta and alpha (IFN-β, IFN-α), are widely used for the treatment of autoimmune demyelination in the central nervous system (CNS). Their effects on de- and remyelination through the broadly expressed type I IFN receptor (IFNAR), however, are highly speculative. In order to elucidate the role of endogenous type I interferons for myelin damage and recovery we induced toxic demyelination in the absence of IFNAR1. We demonstrate that IFNAR signalling was induced during acute demyelination since the cytokine IFN-β as well as the IFN-dependent genes IRF7, ISG15 and UBP43 were strongly upregulated. Myelin damage, astrocytic and microglia response, however, were not significantly reduced in the absence of IFNAR1. Furthermore, motor skills of IFNAR1-deficient animals during non-immune demyelination were unaltered. Finally, myelin recovery was found to be independent from endogenous IFNAR signalling, indicating a redundant role of this receptor for non-inflammatory myelin damage and repair.
Elsevier